Literature DB >> 12203171

Current strategies for management of influenza in the elderly population.

Stefan Gravenstein1, H Edward Davidson.   

Abstract

Influenza virus remains among the most important pathogens infecting elderly people. Vaccination is the most cost-effective strategy to reduce morbidity and mortality due to influenza. For persons who are not vaccinated or for whom vaccines fail to prevent influenza, there are 2 classes of efficacious drugs for treatment or chemoprophylaxis: M2 channel inhibitors and neuraminidase inhibitors. Effective treatment, however, must commence within 48 h of the onset of symptoms, which can create problems for patients who wait to see whether their symptoms worsen or improve. Older adults who have relocated to the congregate housing environments of assisted living and long-term care facilities deserve special consideration, because influenza exposure risks are different for this group. Strategies for control of influenza must combine preventive approaches, such as vaccination, educational approaches, and the introduction of policies that allow health care professionals anticipate, identify, and efficiently respond to influenza outbreaks.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203171     DOI: 10.1086/341246

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  The effectiveness of vaccine day and educational interventions on influenza vaccine coverage among health care workers at long-term care facilities.

Authors:  Akiko C Kimura; Christine N Nguyen; Jeffrey I Higa; Eric L Hurwitz; Duc J Vugia
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

Review 2.  Influenza vaccinations: who needs them and when?

Authors:  Eelko Hak; Arno W Hoes; Theo J M Verheij
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.

Authors:  Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

Review 4.  Reducing the burden of influenza-associated complications with antiviral therapy.

Authors:  B R Ruf; T Szucs
Journal:  Infection       Date:  2009-05-26       Impact factor: 3.553

5.  Comparison of viral isolation and multiplex real-time reverse transcription-PCR for confirmation of respiratory syncytial virus and influenza virus detection by antigen immunoassays.

Authors:  R S Liao; L L Tomalty; A Majury; D E Zoutman
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

6.  Economic evaluations of neuraminidase inhibitors to control influenza.

Authors:  Michaël Schwarzinger; Karine Lacombe; Fabrice Carrat
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2003-04       Impact factor: 2.217

7.  Underdiagnosis of Influenza Virus Infection in Hospitalized Older Adults.

Authors:  Lauren Hartman; Yuwei Zhu; Kathryn M Edwards; Marie R Griffin; H Keipp Talbot
Journal:  J Am Geriatr Soc       Date:  2018-02-13       Impact factor: 5.562

Review 8.  Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.

Authors:  José F Bernardo; Jerry McCauley
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Campaign, counseling and compliance with influenza vaccine among older persons.

Authors:  Vivian Iida Avelino-Silva; Thiago Junqueira Avelino-Silva; Joao Luiz Miraglia; Karina Takesaki Miyaji; Wilson Jacob-Filho; Marta Heloisa Lopes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008.

Authors:  James Mark Simmerman; Malinee Chittaganpitch; Jens Levy; Somrak Chantra; Susan Maloney; Timothy Uyeki; Peera Areerat; Somsak Thamthitiwat; Sonja J Olsen; Alicia Fry; Kumnuan Ungchusak; Henry C Baggett; Supamit Chunsuttiwat
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.